HIV Therapeutics Market to Reach USD 57.56 Billion by 2033 as Long-Acting Regimens, Integrase Inhibitors, and Next-Gen Combination Therapies Redefine Glob…

According to DataM Intelligence, the HIV Therapeutics Market Size grew to USD 37.61 billion in 2024 and is projected to reach ...
FiercePharma

Potential federal budget cuts won't rock Gilead's HIV boat too much: analysts

News of potential federal budget cuts impacting HIV drugs in the U.S. was quickly reflected in a dip in share prices for top HIV drug maker Gilead Sciences last week. But, according to analysts at ...
News-Medical.Net on MSN

Long-acting HIV treatment could improve outcomes for breastfeeding women

Sujata Tewari, BA, previously of the Medical Practice Evaluation Center (MPEC) at Massachusetts General Hospital, and Andrea ...
Commercial Appeal

Forty years ago, AIDS was a death sentence. Not today, but HIV is still a health threat

Lynn Norment, a columnist for The Commercial Appeal, is a former editor for Ebony Magazine. It’s not shocking or even surprising that HIV and AIDS are on the rise in today’s world. The dreaded disease ...
Commercial Appeal

Federal HIV funding rerouted to nonprofits, bypasses Tennessee health department entirely

Nearly three months after the Tennessee Health Department said it would no longer accept and distribute federal funding for HIV prevention-related services, the U.S. Centers for Disease Control and ...